@article{01a7b73a1b174900b990c90bb528b21f,
title = "T-cell lymphomas, version 1.2021 featured updates to the NCCN guidelines",
abstract = "Hepatosplenic T-cell lymphoma (HSTCL) is a rare subtype of T-cell lymphoma associated with an aggressive clinical course and a worse prognosis. HSTCL develops in the setting of chronic immune suppression or immune dysregulation in up to 20% of cases and is most often characterized by spleen, liver, and bone marrow involvement. Diagnosis and management of HSTCL pose significant challenges given the rarity of the disease along with the absence of lymphadenopathy and poor outcome with conventional chemotherapy regimens. These Guidelines Insights focus on the diagnosis and treatment of HSTCL as outlined in the NCCN Guidelines for T-Cell Lymphomas.",
author = "Horwitz, {Steven M.} and Stephen Ansell and Ai, {Weiyun Z.} and Jeffrey Barnes and Barta, {Stefan K.} and Clemens, {Mark W.} and Ahmet Dogan and Goodman, {Aaron M.} and Gaurav Goyal and Joan Guitart and Ahmad Halwani and Haverkos, {Bradley M.} and Hoppe, {Richard T.} and Eric Jacobsen and Deepa Jagadeesh and Allison Jones and Kim, {Youn H.} and Neha Mehta-Shah and Olsen, {Elise A.} and Barbara Pro and Rajguru, {Saurabh A.} and Sima Rozati and Jonathan Said and Aaron Shaver and Andrei Shustov and Lubomir Sokol and Pallawi Torka and Carlos Torres-Cabala and Ryan Wilcox and William, {Basem M.} and Jasmine Zain and Dwyer, {Mary A.} and Hema Sundar",
note = "Publisher Copyright: {\textcopyright} 2020 Harborside Press. All rights reserved.",
year = "2020",
month = nov,
doi = "10.6004/JNCCN.2020.0053",
language = "English (US)",
volume = "18",
pages = "1460--1467",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Harborside Press",
number = "11",
}